A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Beth Israel Med. Ctr. (Mt. Sinai), New York

NY Univ. HIV/AIDS CRS, New York

Weill Med. College of Cornell Univ., The Cornell CTU, New York

Mt. Sinai Med. Ctr. (N.Y.) A1801 CRS, New York

Duke Univ. Med. Ctr. Adult CRS, Durham

Alabama Therapeutics CRS, Birmingham

Case CRS, Cleveland

Univ. of Iowa Healthcare, Div. of Infectious Diseases, Iowa City

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Tulane Univ. A1701 CRS, New Orleans

University of Colorado Hospital CRS, Aurora

Harbor-UCLA Med. Ctr. CRS, Torrance

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

Unc Aids Crs, Chapel Hill

The Ohio State Univ. AIDS CRS, Columbus

Univ. of Texas Medical Branch, ACTU, Galveston

USC CRS, Los Angeles

Stanford CRS, Palo Alto

University of Washington AIDS CRS, Seattle

Beth Israel Deaconess - East Campus A0102 CRS, Boston